News
Media
Conferences
Resources
Publications
Events
Business
Practice Type
Subscribe
Total Pharmacy

Madeleine Depinho, BS, PharmD Candidate 2022

Articles by Madeleine Depinho, BS, PharmD Candidate 2022

migraine

New Drug Review: Atogepant FDA-Approved for Migraine Treatment

ByMadeleine Depinho, BS, PharmD Candidate 2022,Cassandra R. Doyno, PharmD, BCPS, BCCCP

December 15th 2021

On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.

Latest Updated Articles

Trending on Drug Topics

Pneumococcal Conjugate Vaccines Reduces Incidence of Pneumonia for Children 2 Years and Under

© 2025 MJH Life Sciences^®

All rights reserved.